Advanced search
Add to list

Promoter CpG island hypermethylation of Decoy Receptor 1 (DCR1) is associated with poor response to irinotecan in metastatic colorectal cancer

(2014) VIRCHOWS ARCHIV. 465(suppl. 1). p.S326-S326
Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
Bosch, L., et al. “Promoter CpG Island Hypermethylation of Decoy Receptor 1 (DCR1) Is Associated with Poor Response to Irinotecan in Metastatic Colorectal Cancer.” VIRCHOWS ARCHIV, vol. 465, no. suppl. 1, 2014, pp. S326–S326.
APA
Bosch, L., Trooskens, G., Snaebjornsson, P., Haan, J., Koopman, M., Tol, J., … Meijer, G. (2014). Promoter CpG island hypermethylation of Decoy Receptor 1 (DCR1) is associated with poor response to irinotecan in metastatic colorectal cancer. VIRCHOWS ARCHIV, 465(suppl. 1), S326–S326.
Chicago author-date
Bosch, L, G Trooskens, P Snaebjornsson, J Haan, M Koopman, J Tol, T de Meyer, et al. 2014. “Promoter CpG Island Hypermethylation of Decoy Receptor 1 (DCR1) Is Associated with Poor Response to Irinotecan in Metastatic Colorectal Cancer.” In VIRCHOWS ARCHIV, 465:S326–S326.
Chicago author-date (all authors)
Bosch, L, G Trooskens, P Snaebjornsson, J Haan, M Koopman, J Tol, T de Meyer, J Louwagie, L Dehaspe, NCT van Grieken, B Ylstra, H Verheul, M van Engeland, I Nagtegaal, JG Herman, CJA Punt, Wim Van Criekinge, B Carvalho, and GA Meijer. 2014. “Promoter CpG Island Hypermethylation of Decoy Receptor 1 (DCR1) Is Associated with Poor Response to Irinotecan in Metastatic Colorectal Cancer.” In VIRCHOWS ARCHIV, 465:S326–S326.
Vancouver
1.
Bosch L, Trooskens G, Snaebjornsson P, Haan J, Koopman M, Tol J, et al. Promoter CpG island hypermethylation of Decoy Receptor 1 (DCR1) is associated with poor response to irinotecan in metastatic colorectal cancer. In: VIRCHOWS ARCHIV. 2014. p. S326–S326.
IEEE
[1]
L. Bosch et al., “Promoter CpG island hypermethylation of Decoy Receptor 1 (DCR1) is associated with poor response to irinotecan in metastatic colorectal cancer,” in VIRCHOWS ARCHIV, London, UK, 2014, vol. 465, no. suppl. 1, pp. S326–S326.
@inproceedings{5936613,
  articleno    = {{abstract PS-20_049}},
  author       = {{Bosch, L and Trooskens, G and Snaebjornsson, P and Haan, J and Koopman, M and Tol, J and de Meyer, T and Louwagie, J and Dehaspe, L and van Grieken, NCT and Ylstra, B and Verheul, H and van Engeland, M and Nagtegaal, I and Herman, JG and Punt, CJA and Van Criekinge, Wim and Carvalho, B and Meijer, GA}},
  booktitle    = {{VIRCHOWS ARCHIV}},
  issn         = {{0945-6317}},
  language     = {{eng}},
  location     = {{London, UK}},
  number       = {{suppl. 1}},
  pages        = {{abstract PS-20_049:S326--abstract PS-20_049:S326}},
  title        = {{Promoter CpG island hypermethylation of Decoy Receptor 1 (DCR1) is associated with poor response to irinotecan in metastatic colorectal cancer}},
  volume       = {{465}},
  year         = {{2014}},
}

Web of Science
Times cited: